Physician

Hematology

Dr. David L. Grinblatt works in the field of Hematology. He researched medicine at Case Western Reserve University School of Medicine. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". David Grinblatt is also a published doctor. He has 20 paper published. The most recent paper is: A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patient... David Grinblatt is registered with Medicare and accepts Medicare payments.

Publications

---

• Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
• Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
• Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
• Autologous and allogeneic transplantation for aggressive NHL.
• Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP.
• Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.
• Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck.
• High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
• A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patient...
• Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma.
• A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer.
• Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancer.
• Review: coagulopathy and factor inhibitors.
• Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
• Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in pat...
• Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
• Response of pancreatic carcinoma to 5-fluorouracil and leucovorin.
• Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
• Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.

Schools

---

• Case Western Reserve University School of Medicine

• Northwestern Memorial Hospital

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis
• Thoracentesis

Doctors Specialties

---

• Hematology
• Internal Medicine
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Super Doctor

Education

---

• McGaw Medical Center of Northwestern University
• Rush University Medical Center
• Case Western Reserve University School of Medicine

Hospital

---

• NorthShore University Health System
• NorthShore Skokie Hospital

Drug Facts

---

NPI NUMBER		1548285372
NPPES Provider LastName		GRINBLATT
NPPES Provider FirstName		DAVID
NPPES Provider ZIPCode		602011718
NPPES Provider State		IL
Specialty Description		Hematology/Oncology
Total Claim Count		895.0
Distinct Opioid Count		3.0
Opioid Claim Count		58.0
Percent Opioid Claims		6.48

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1548285372
Last Name Of The Provider	GRINBLATT
First Name Of The Provider	DAVID
View All

Similar Doctors

---

	Dr. Henri Frischer, MD
	Dr. Frank J. Weschler, MD This Doctor is OpenDoctor Recommended.
	Dr. Aron H. Feinberg, DO This Doctor is OpenDoctor Recommended.
	Dr. Elaine L. Wade, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer C. Obel, MD This Doctor is OpenDoctor Recommended.
	Dr. Lynne S. Kaminer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Britt E. Hanson, DO This Doctor is OpenDoctor Recommended.
	Dr. Michael A. Ellison, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Thomas R. Sultan, MD This Doctor is OpenDoctor Recommended.
	Dr. Margaret L. Thomas, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey Ryan, MD
	Dr. Stephen R. Morse, MD This Doctor is OpenDoctor Recommended.
	Dr. May Hashimi, MD This Doctor is OpenDoctor Recommended.
	Dr. Alla Gimelfarb, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian T. Helfand, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog